Cadila Pharmaceuticals reports barcode error on Mirtazapine 30mg tablets

Cadila Pharmaceuticals Limited has informed the Medicines and Healthcare products Regulatory Agency (MHRA) of an error with the European Article Number (EAN) barcode on the cartons of a batch of Mirtazapine 30mg film-coated tablets. The affected cartons were distributed in the livery of Crescent Pharma Limited. The notification is recorded as a Class 4 medicines defect. The error pertains solely to the barcode labeling on the outer packaging and does not affect the tablet composition or safety. Cadila and the MHRA are working to correct the labeling issue and advise stakeholders as needed.